1. Home
  2. JAGX vs AIXI Comparison

JAGX vs AIXI Comparison

Compare JAGX & AIXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.63

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

AIXI

XIAO-I Corporation

HOLD

Current Price

$0.23

Market Cap

3.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAGX
AIXI
Founded
2013
2001
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
3.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
JAGX
AIXI
Price
$0.63
$0.23
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
9.3M
1.4M
Earning Date
03-30-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,785,000.00
$48,877,458.00
Revenue This Year
$22.41
$26.84
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.45
N/A
52 Week Low
$0.56
$0.19
52 Week High
$25.75
$5.49

Technical Indicators

Market Signals
Indicator
JAGX
AIXI
Relative Strength Index (RSI) 42.22 35.52
Support Level $0.56 $0.20
Resistance Level $0.69 $0.28
Average True Range (ATR) 0.06 0.05
MACD 0.01 0.01
Stochastic Oscillator 42.23 18.91

Price Performance

Historical Comparison
JAGX
AIXI

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About AIXI XIAO-I Corporation

XIAO-I Corp is an AI industrialization company focusing on the AI Cognitive Intelligence platform. The platform combines six core technologies including Natural Language Processing, Speech Processing, Computer Vision, Machine Learning, Affective Computing, Data Intelligence, and Hyper- automation. Based on the platform, The company developed products and solutions in the fields of Al+ Contact Center, Al+ Finance, Al+ City Public Service, Al+ Architecture, Al+ Metaverse, Al+ Manufacturing, and Al+ Healthcare. It generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Share on Social Networks: